Please find enclosed herewith the Intimation regarding the Closure of Trading Window.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma has informed the stock exchanges that the trading window for its shares will be closed for insiders, designated persons, and their immediate relatives starting April 1, 2026. The window will reopen only 48 hours after the company announces its audited financial results for the financial year ending March 31, 2026. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, aimed at preventing insider trading ahead of the results announcement. The date of the board meeting to approve the audited results has not yet been disclosed and will be communicated separately.
No direct impact on shareholders or stock price. This is a standard regulatory filing signalling that audited FY26 results are upcoming, which may bring volatility once announced.